Focus on medication errors caused by confusion of a newly introduced medicinal product with an authorised/established one, containing the same active substance but different in some aspects.
Adoption by CHMP for release for consultation 24 May 2012
Start of public consultation 1 June 2012
End of consultation (deadline for comments) 30 November 2012
Adoption by CHMP 30 May 2013
Date of coming into effect 1 June 2013